In the present work, we aimed to briefly summarize current knowledge on H4R pharmacology and H4R ligands clinical use before focusing on recent data reporting the expression of H4R and its pathophysiological role in cancer, representing a potential molecular target for cancer therapeutics. Here, HRH4 is linked to cancer.